BINH DINH PHARMACEUTICAL AND MEDICAL EQUIPMENT |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40,650 VND | +0.87% |
|
+1.62% | -6.25% |
| Sales 2024 * | 1,844B 71.92M | Sales 2025 * | - | Capitalization | 3,803B 148M |
|---|---|---|---|---|---|
| Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 2.06 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 1,318 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 62.31% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.87% | ||
| 1 week | +1.62% | ||
| Current month | +1.62% | ||
| 1 month | -3.40% | ||
| 3 months | -8.61% | ||
| 6 months | -6.59% | ||
| Current year | -6.25% |
1 week
39 200.00
41 000.00
1 month
39 000.0043 500.00
Current year
39 000.0045 920.00
1 year
39 000.0048 000.00
3 years
24 615.3848 000.00
5 years
23 440.5648 000.00
10 years
19 580.4248 000.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 59 | 09-12-31 | |
Qua Van Nguyen
CHM | Chairman | 63 | 83-04-30 |
Dung Tan Dang
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Lam Minh Dau
BRD | Director/Board Member | 45 | 21-04-16 |
Qua Van Nguyen
CHM | Chairman | 63 | 83-04-30 |
| Chief Executive Officer | 59 | 09-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-07-05 | 40,650 | +0.87% | 1,592,400 |
| 24-07-04 | 40,300 | +2.03% | 132,900 |
| 24-07-03 | 39,500 | -0.13% | 174,000 |
| 24-07-02 | 39,550 | -0.63% | 43,000 |
| 24-07-01 | 39,800 | -0.50% | 25,400 |
End-of-day quote Ho Chi Minh S.E., July 04, 2024
More quotes
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company (Bidiphar) is a Vietnam-based company primarily engaged in pharmaceuticals sector. The Company's leading business activities are the production and wholesale of medicines, including antibiotics, antipyretics, pain relievers, cardiovascular drugs, antifungal and antiviral drugs, respiratory drugs, vitamins and functional food, among others. Bidiphar is also involved in the manufacture and distribution of medical equipment, supplies and packaging.
Sector
Pharmaceuticals
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
40,650
VND
Average target price
48,000
VND
Spread / Average Target
+18.08%
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -6.25% | 150M | |
| +24.53% | 45.07B | |
| +30.99% | 23.39B | |
| +24.13% | 16.08B | |
| +21.15% | 14.6B | |
| +68.67% | 14.01B | |
| -0.05% | 6.79B | |
| -13.29% | 6.38B | |
| -8.87% | 5.73B | |
| +13.53% | 5.64B |
- Stock Market
- Equities
- DBD Stock
